EUVIMEDEUVIMED entdecken
Crossref

Proenkephalin predicts kidney function and major adverse kidney events in CKD

Marleen Würfel iD, Luise Pirlich, Ekaterine Baratashvili, Emma Dahlström, Fabian Baalmann, Anette Bachmann, Jana Breitfeld, Ralph Wendt, Ronny Baber, Martin Haussmann, Ingolf Bast, Joachim Beige iD und 7 weitere

Nephrology Dialysis Transplantation · 2026

DOI: 10.1093/ndt/gfaf214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Marleen Würfel und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, Division of Endocrinology, Nephrology and Rheumatology, University of Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Enkephalins, Renal Insufficiency, Chronic, Protein Precursors, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: German Research Foundation, Novo Nordisk, Karolinska Institutet Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis The endogenous opioid proenkephalin (PENK) has been identified as an independent risk marker for acute cardiovascular diseases and acute kidney injury. However, its regulation, its association with other cardiometabolic markers and its prognostic role in patients with chronic kidney disease (CKD) have not been thoroughly investigated.

Methods

PENK serum levels were cross-sectionally related to renal and cardiometabolic markers across three large cohorts (total N = 4722), including the Leipzig-CKD cohort (N = 581), as well as the population-based LIFE-Adult (N = 3093) and Sorbs (N = 1048) cohort. Furthermore, a longitudinal analysis was performed in the Leipzig-CKD cohort to assess the association between circulating PENK levels at baseline and a composite 4-point major adverse renal events (4P-MAKE) endpoint comprising incident or worsening kidney disease, development of kidney failure (KF) requiring kidney replacement therapy or kidney transplantation, and renal deaths.

Results

In the entire cross-sectional cohort (N = 4722), PENK levels were strongly and inversely correlated with markers of renal function, i.e. estimated glomerular filtration rate (eGFR), creatinine and urinary albumin–creatinine ratio. In multivariable analysis, eGFR was the strongest, independent and inverse predictor of circulating PENK levels after adjustment for age and sex, as well as markers of obesity, glucose intolerance, dyslipidemia and inflammation. Multivariable Cox regression analysis revealed that baseline circulating PENK levels were strongly associated with an increased risk of the 4P-MAKE over a median follow-up of 8.7 years. Each doubling of PENK levels was associated with a >2-fold increase in the risk of developing 4P-MAKE, even after adjusting for various clinical and metabolic variables. PENK provided added value for predicting adverse renal outcomes.

Conclusions

PENK levels are strongly, independently, and inversely associated with renal function in cross-sectional analysis. Furthermore, baseline circulating PENK levels are predictive of a 4P-MAKE in patients and added independent, prognostic value for identification of patients at risk for adverse renal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnkephalinsRenal Insufficiency, ChronicProtein PrecursorsBiomarkersHumansMaleFemaleCross-Sectional StudiesMiddle AgedGlomerular Filtration RatePrognosisFollow-Up StudiesAgedKidney Function TestsLongitudinal StudiesAdultRisk Factors

Stichwörter der Autor:innen

cardiometabolic diseasemajor adverse renal eventsproenkephalinrenal function

Substanzen

proenkephalinEnkephalinsProtein PrecursorsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine III, Division of Endocrinology, Nephrology and Rheumatology, University of Leipzig, Leipzig, Germany.
  • Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland.
  • Department of Nephrology, Hospital St Georg Leipzig, Leipzig, Germany.
  • Leipzig Medical Biobank, University of Leipzig, 04103 Leipzig, Germany.
  • Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics (ILM), University Hospital Leipzig, 04103 Leipzig, Germany.
  • Nierenzentrum Leipzig, Outpatient Care Units, 04178 Leipzig, Germany.

ORCID-Profile: Marleen Würfel, Joachim Beige, Berend Isermann, Peter Kovacs, Michael Stumvoll, Robin Schürfeld, Anke Tönjes, Thomas Ebert

Förderung

  • German Research Foundation
  • Novo Nordisk
  • Karolinska Institutet Research Foundation
  • Njurfonden
  • German Diabetes Association
  • AstraZeneca
  • ERC

Zitieren

APA

Würfel, M., Pirlich, L., Baratashvili, E., Dahlström, E., Baalmann, F., Bachmann, A., Breitfeld, J., Wendt, R., Baber, R., Haussmann, M., Bast, I., Beige, J., Isermann, B., Kovacs, P., Blüher, M., Stumvoll, M., Schürfeld, R., Tönjes, A., & Ebert, T. (2026). Proenkephalin predicts kidney function and major adverse kidney events in CKD. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf214

Vancouver

Würfel M, Pirlich L, Baratashvili E, Dahlström E, Baalmann F, Bachmann A, et al. Proenkephalin predicts kidney function and major adverse kidney events in CKD. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf214

BibTeX
@article{Wrfel2026,
  author = {Würfel, Marleen and Pirlich, Luise and Baratashvili, Ekaterine and Dahlström, Emma and Baalmann, Fabian and Bachmann, Anette and Breitfeld, Jana and Wendt, Ralph and Baber, Ronny and Haussmann, Martin and Bast, Ingolf and Beige, Joachim and Isermann, Berend and Kovacs, Peter and Blüher, Matthias and Stumvoll, Michael and Schürfeld, Robin and Tönjes, Anke and Ebert, Thomas},
  title = {Proenkephalin predicts kidney function and major adverse kidney events in CKD},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfaf214}
}
Kostenlos starten →